Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital

References

• Charache S, Scott JC, Charache P. Acute chest syndrome in adults with sickle cell anemia: microbiology, treatment, and prevention. Arch Intern Med. 1979;139(1):67–69.
   PubMedGoogle Scholar
• Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National acute chest syndrome study group. N Engl J Med. 2000;342(25):1855–1865.
   PubMed Web of Science ®Google Scholar
• Miller AC, Gladwin MT. Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med. 2012;185(11):1154–1165.
   PubMed Web of Science ®Google Scholar
• Homi J, Levee L, Higgs D, et al. Pulse oximetry in a cohort study of sickle cell disease. Clin Lab Haematol. 1997;19(1):17–22.
   PubMedGoogle Scholar
• Howard J, Hart N, Roberts-Harewood M, BCSH Committee. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169(4):492–505.
   PubMed Web of Science ®Google Scholar
• Ahmed SG. The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease. Mediterr J Hematol Infect Dis. 2011;3(1):e2011028.
   PubMedGoogle Scholar
• Chang TP, Kriengsoontorkij W, Chan LS, et al. Clinical factors and incidence of acute chest syndrome or pneumonia among children with sickle cell disease presenting with a fever: a 17-year review. Pediatr Emerg Care. 2013;29(7):781–786.
   PubMed Web of Science ®Google Scholar
• Davies EG, Riddington C, Lottenberg R, et al. Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev. 2004;1:CD003885.
   Google Scholar
• Goldblatt D, Johnson M, Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. Arch Dis Child. 1996;75(2):159–161.
   PubMed Web of Science ®Google Scholar
• Strouse JJ, Reller ME, Bundy DG, et al. Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease. Blood. 2010;116(18):3431–3434.
   PubMed Web of Science ®Google Scholar
• Dorn-Beineke A, Frietsch T. Sickle cell disease-pathophysiology, clinical and diagnostic implications. Clin Chem Lab Med. 2002;40(11):1075–1084.
   PubMed Web of Science ®Google Scholar
• Hatzipantelis ES, Pana ZD, Gombakis N, et al. Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease. Int J Hematol. 2013;98(2):158–163.
   PubMed Web of Science ®Google Scholar
• Zhang D, Xu C, Manwani D, et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016;127(7):801–809.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program. 2007;2007(1):91–96.
   Google Scholar
• Freestone B, Lip GYH, Chong AY, et al. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Thromb Haemost. 2005;94(4):702–706.
   PubMed Web of Science ®Google Scholar
• Mekontso Dessap A, Leon R, Habibi A, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2008;177(6):646–653.
   PubMed Web of Science ®Google Scholar
• Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6(2):359–365.
   PubMed Web of Science ®Google Scholar
• Cohen RT, DeBaun MR, Blinder MA, et al. Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease. Blood. 2010;115(18):3852–3854.
   PubMed Web of Science ®Google Scholar
• Michas G, Karvelas G, Trikas A. Cardiovascular disease in Greece; the latest evidence on risk factors. Hellenic J Cardiol. 2019;60(5):271–275.
   PubMed Web of Science ®Google Scholar
• Emre U, Miller ST, Gutierez M, et al. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr. 1995;127(6):901–904.
   PubMed Web of Science ®Google Scholar
• Turner JM, Kaplan JB, Cohen HW, et al. Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults. Transfusion. 2009;49(5):863–868.
   PubMed Web of Science ®Google Scholar
• Chou ST, Alsawas M, Fasano RM, et al. American society of hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327–355.
   PubMed Web of Science ®Google Scholar
• Chaplin H Jr, Monroe MC, Malecek AC, et al. Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises. East Afr Med J. 1989;66(9):574–584.
   PubMedGoogle Scholar
• Qari MH, Aljaouni SK, Alardawi MS, et al. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. Thromb Haemost. 2007;98(08):392–396.
   PubMedGoogle Scholar
• Ogunlesi F, Koumbourlis AC. Sickle cell disease and the lung: many questions still remain unanswered. Clin Pulm Med. 2011;18(3):119–128.
   Google Scholar
• McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol. 2011;18(3):158–165.
   PubMed Web of Science ®Google Scholar
• Telen MJ. Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease. Blood. 2016;127(7):810–819.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Kutlar A, Kanter J, et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017;376(5):429–439.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative study of sickle cell disease. Blood. 1997;89(5):1787–1792.
   PubMed Web of Science ®Google Scholar